Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.71 USD | +2.17% | +1.97% | +13.11% |
03:10pm | Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating | MT |
09/05 | Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.11% | 158M | |
+23.65% | 44.96B | |
+1.36% | 42.65B | |
+46.11% | 41.85B | |
-4.27% | 29.04B | |
+11.15% | 26.08B | |
-20.57% | 19.03B | |
+6.92% | 12.75B | |
+28.30% | 12.06B | |
-4.08% | 11.75B |
- Stock Market
- Equities
- ACHV Stock
- News Achieve Life Sciences, Inc.
- Transcript : Achieve Life Sciences, Inc., Q2 2023 Earnings Call, Aug 15, 2023